Cisen Pharmaceutical Co Ltd Tangible Net Worth Ratio
Cisen Pharmaceutical Co Ltd tangible net worth ratio. Cisen Pharmaceutical Co Ltd (603367) has a Tangible Net Worth Ratio of 96.9% as of June 2026. This metric is calculated by deducting intangible assets (CN¥196.84 Million) from net assets (CN¥6.42 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Cisen Pharmaceutical Co Ltd (603367) strategic asset index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Cisen Pharmaceutical Co Ltd (2011–2025)
Tangible net worth ratio of Cisen Pharmaceutical Co Ltd from 2011 to 2025. This chart shows how Cisen Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 96.9%, reflecting net assets of CN¥6.42 Billion with intangible assets of CN¥196.84 Million CNY. See 603367 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Cisen Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2011–2025)
Cisen Pharmaceutical Co Ltd tangible net worth ratio by year from 2011 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Cisen Pharmaceutical Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Cisen Pharmaceutical Co Ltd (603367) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.8% | CN¥6.23 Billion | CN¥196.29 Million | CN¥7.60 Billion | ▲ +0.3 pp |
| 2024 | 96.6% | CN¥5.99 Billion | CN¥203.97 Million | CN¥7.55 Billion | ▲ +0.3 pp |
| 2023 | 96.3% | CN¥5.77 Billion | CN¥211.60 Million | CN¥7.34 Billion | ▲ +0.3 pp |
| 2022 | 96.0% | CN¥5.36 Billion | CN¥213.03 Million | CN¥6.82 Billion | ▲ +0.2 pp |
| 2021 | 95.8% | CN¥5.06 Billion | CN¥210.82 Million | CN¥6.36 Billion | ▲ +0.2 pp |
| 2020 | 95.7% | CN¥4.80 Billion | CN¥207.92 Million | CN¥6.17 Billion | ▲ +0.2 pp |
| 2019 | 95.5% | CN¥4.57 Billion | CN¥208.02 Million | CN¥5.53 Billion | ▲ +0.0 pp |
| 2018 | 95.5% | CN¥4.15 Billion | CN¥188.98 Million | CN¥5.25 Billion | ▲ +0.5 pp |
| 2017 | 94.9% | CN¥3.72 Billion | CN¥189.14 Million | CN¥4.74 Billion | ▲ +3.1 pp |
| 2016 | 91.8% | CN¥2.30 Billion | CN¥188.03 Million | CN¥3.28 Billion | ▲ +0.8 pp |
| 2015 | 91.0% | CN¥2.10 Billion | CN¥188.41 Million | CN¥3.03 Billion | ▲ +1.0 pp |
| 2014 | 90.0% | CN¥1.90 Billion | CN¥189.64 Million | CN¥2.69 Billion | ▼ -0.1 pp |
| 2013 | 90.1% | CN¥1.73 Billion | CN¥170.77 Million | CN¥2.36 Billion | ▼ -4.6 pp |
| 2012 | 94.7% | CN¥1.58 Billion | CN¥83.72 Million | CN¥2.05 Billion | ▲ +1.1 pp |
| 2011 | 93.6% | CN¥1.34 Billion | CN¥85.38 Million | CN¥1.57 Billion | — |